Literature DB >> 16197651

Alcoholic hepatitis: from pathogenesis to treatment.

S Sougioultzis1, E Dalakas, P C Hayes, J N Plevris.   

Abstract

UNLABELLED: Alcoholic hepatitis is a serious complication of alcohol abuse due to its high mortality rates particularly at short term. It may complicate pre-existing alcoholic fatty liver or cirrhosis and is mainly diagnosed on clinical and laboratory grounds although liver biopsy is occasionally needed to exclude other pathology and confirm the diagnosis. Accumulating evidence suggests that cytokines and immunity are actively involved in its pathogenesis. Management includes abstinence and supportive care. Treatment with corticosteroids has been studied in several clinical trials with conflicting results. However, recent evidence supporting the beneficial effect of TNF-alpha inhibition provides an encouraging alternative. Here we summarise the current state in diagnosis and management of alcoholic hepatitis and briefly review the latest advances in pathophysiology that may lead to new therapeutic strategies for this difficult clinical condition. DATA SOURCES: Medline 1966-2005, EMBASE/Excerpta Medica 1980-2005, The Cochrane Library (2005 Issue 2) and contact with authors of published reports.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197651     DOI: 10.1185/030079905X56493

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  8 in total

Review 1.  Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Authors:  Won Kim; Dong Joon Kim
Journal:  World J Hepatol       Date:  2014-10-27

2.  Comparison of Maddrey Discriminant Function, Child-Pugh Score and Glasgow Alcoholic Hepatitis Score in predicting 28-day mortality on admission in patients with acute hepatitis.

Authors:  S Ali; S Hussain; M Hair; A A Shah
Journal:  Ir J Med Sci       Date:  2012-04-28       Impact factor: 1.568

Review 3.  Current concepts and controversies in the treatment of alcoholic hepatitis.

Authors:  Catherine Rongey; Neil Kaplowitz
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

Review 4.  Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment.

Authors:  Maneerat Chayanupatkul; Suthat Liangpunsakul
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Neoboutonia melleri var velutina Prain: in vitro and in vivo hepatoprotective effects of the aqueous stem bark extract on acute hepatitis models.

Authors:  Anne Marie Endougou Effa; Emilie Gantier; Thierry Hennebelle; Vincent Roumy; Céline Rivière; Théophile Dimo; Pierre Kamtchouing; Pierre Desreumaux; Laurent Dubuquoy
Journal:  BMC Complement Altern Med       Date:  2018-01-22       Impact factor: 3.659

6.  Cilostazol Decreases Ethanol-Mediated TNFalpha Expression in RAW264.7 Murine Macrophage and in Liver from Binge Drinking Mice.

Authors:  Youn Ju Lee; Jong Ryeol Eun
Journal:  Korean J Physiol Pharmacol       Date:  2012-04-24       Impact factor: 2.016

7.  Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis.

Authors:  Minjong Lee; Won Kim; Yunhee Choi; Sunhee Kim; Donghee Kim; Su Jong Yu; Jeong-Hoon Lee; Hwi Young Kim; Yong Jin Jung; Byeong Gwan Kim; Yoon Jun Kim; Jung-Hwan Yoon; Kook Lae Lee; Hyo-Suk Lee
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

Review 8.  Emerging concepts in alcoholic hepatitis.

Authors:  Phoenix Fung; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2017-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.